Moreover, SLC2A3 expression was significant up-regulated in T3 + T4 groups (Figure 2C), N1 + N2 groups (Figure 2D), TNM III + IV groups (Figure 2E), MSI-H groups (Figure 2F), lymphatic invasion groups (Figure 2G) and mucous adenocarcinoma groups (Figure 2H). The gene discussed is SLC2A3; the disease is mucinous adenocarcinoma.